NEW HAYESBANK SURGERY
BYBROOK, KENNINGTON, ASHFORD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 19 | 25 | 76.0% | |
| HF 4 | 2011 | 20 | 25 | 80.0% | |
| HF 4 | 2012 | 23 | 29 | 79.3% | |
| HF 4 | 2013 | 36 | 43 | 83.7% | |
| HF004 | 2014 | 29 | 34 | 85.3% | |
| HF004 | 2015 | 26 | 31 | 83.9% | |
| HF004 | 2016 | 46 | 53 | 86.8% | |
| HF004 | 2017 | 44 | 53 | 83.0% | |
| HF004 | 2018 | 39 | 43 | 90.7% | |
| HF004 | 2019 | 37 | 39 | 94.9% | |
| HF004 | 2020 | 56 | 60 | 93.3% | |
| HF006 | 2021 | 51 | 57 | 89.5% | |
| HF006 | 2022 | 68 | 68 | 100.0% | |
| HF006 | 2023 | 76 | 80 | 95.0% |
